Maria Laura Martin

10PUBLICATIONS
144CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

|Feb 01, 2025
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition.

Florencia P Madorsky Rowdo, Rachel Martini, Sarah E Ackermann

|Sep 26, 2024
Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1<sup>+</sup> progenitor CD8<sup>+</sup> T cells to improve immunotherapy.

Geoffrey J Markowitz, Yi Ban, Diamile A Tavarez

|Jul 29, 2024
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer.

Tito A Sandoval, Camilla Salvagno, Chang-Suk Chae

|Mar 15, 2024
Gut bacteria-derived serotonin promotes immune tolerance in early life.

Katherine Z Sanidad, Stephanie L Rager, Hannah C Carrow

|Dec 11, 2023
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.

Florencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova

Pageof 2

Frequent Collaborators

4 joint publications

Olivier Elemento

4 joint publications

Florencia P Madorsky Rowdo

3 joint publications

Nasser K Altorki

3 joint publications

Lisa Newman